
Keywords: CFA; complete Freund's adjuvant; CNS; central nervous system; c.s.; clinical signs; DA; dark agouti; EAE; Eexperimental autoimmune encephalomyelitis; EP; ethyl pyruvate; GALT; gut-associated lymphoid tissue; IFN; interferon; IL; nterleukin; MLN; mesente